Top Markets
#1 Black Phoenix Black Phoenix +826.34%
#2 pipedog pipedog +28.14%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.27%
#4 SAFEcoin SAFEcoin +25.29%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +23.78%
#6 Bless Bless +22.81%
#7 PondCoin PondCoin +19.97%
#8 Beam Beam +19.73%
#9 Magma Finance Magma Finance +19.65%
#10 Asteroid Shiba Asteroid Shiba +17.65%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
Zenas BioPharma, Inc. Zenas BioPharma, Inc.

Zenas BioPharma, Inc.

ZBIO
주식 순위 #6395
Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm,... Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. Its developmental portfolio also features ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Established in 2019, the entity was formerly recognized as Zenas BioPharma (Cayman) Limited before adopting its current name, Zenas BioPharma, Inc., in August 2023. Its headquarters are located in Waltham, Massachusetts.
주가
$32.88
시가총액
$2.08B
변동 (1일)
-0.48%
변동 (1년)
96.77%
국가
US
거래 Zenas BioPharma, Inc. (ZBIO)

카테고리

Healthcare
Zenas BioPharma, Inc. (ZBIO)의 매출
Aug 2026 기준 매출 TTM: 0
Zenas BioPharma, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Zenas BioPharma, Inc.의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH